Saphnelo (Anifrolumab) is a biologic medicine that is used to treat lupus. It works by suppressing part of the body's immune system.
Saphnelo works by blocking type 1 interferon, which is a type of signalling protein (called a cytokine), that is a driver of the disease activity in lupus.
Saphnelo is given as an intravenous infusion (IV) by a trained nurse in a clinic.
The manufacturer of Saphnelo offers a support program to Canadian patients that are prescribed the medication:Patient support program enrolment forms
Important Tests and Risks
Drug Identification Number (DIN)